The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

Basu, SandipOstwal, V.2017-03-092017-03-092016European Journal of Nuclear Medicine and Molecular Imaging, 2016. Vol. 43 (13): pp. 2453-2455http://hdl.handle.net/123456789/141533356 bytestext/htmlenNeuroendocrine tumorPeptide receptor radionuclide therapy68Ga-DOTATATEFDG-PET/CTChemotherapy177Lu-DOTATATEThe case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenariosArticle